SCHEMBL5077440

SCHEMBL5077440

CCCCCCCCCCCCCCOC(=O)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASAH1 Q13510 1/20 0.57
ALDH1A1 P00352 4/20 0.54
TSHR P16473 3/20 0.54
LMNA P02545 2/20 0.54
BCHE P06276 1/20 0.52
TP53 P04637 1/20 0.51
CYP3A4 P08684 1/20 0.51
MAPK1 P28482 1/20 0.51
KDM4E B2RXH2 2/20 0.48
HSD17B10 Q99714 2/20 0.48
POLB P06746 1/20 0.48
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
NR1H2 P55055 1/20 0.44
NR1H3 Q13133 1/20 0.44
HPGD P15428 1/20 0.44
PPARG P37231 3/20 0.44
MMP1 P03956 1/20 0.43
MMP9 P14780 1/20 0.43
MMP12 P39900 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7104032 0.98 ASAH1 (0.55) ASAH1ALDH1A1TSHRLMNABCHE
SCHEMBL11782335 0.94 BCHE (0.58) ASAH1ALDH1A1TSHRLMNABCHE
SCHEMBL8995177 0.87 ALDH1A1 (0.62) ASAH1ALDH1A1LMNABCHEL3MBTL1
SCHEMBL31241181 0.82 L3MBTL1 (0.55) ASAH1ALDH1A1TSHRBCHEHSD17B10
SCHEMBL74973 0.82 L3MBTL1 (0.55) ASAH1ALDH1A1TSHRBCHEHSD17B10
SCHEMBL25249669 0.81 NAAA (0.47) ALDH1A1TSHRLMNABCHETP53
SCHEMBL10455469 0.79 ALDH1A1 (0.78) ALDH1A1TSHRLMNAL3MBTL1MEN1
SCHEMBL4349429 0.79 ALDH1A1 (0.51) ASAH1ALDH1A1TSHRLMNATP53
SCHEMBL10455775 0.79 ALDH1A1 (0.78) ALDH1A1TSHRLMNAL3MBTL1MEN1
SCHEMBL10455773 0.78 ALDH1A1 (0.50) ASAH1ALDH1A1TSHRLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7368615-B2 Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2008-05-06 US disclosed
US-20060036100-A1 Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst ISHII YASUTAKA 2006-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060036100-A1 Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst NOX4, NOX1, POR ASAH1 4606/4885ALDH1A1 1439/4885TSHR 3276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.